As of June 1, 2025, Luckwel Pharmaceuticals Inc (LWEL) reports a ROA (Return on Assets) of -934.04%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Luckwel Pharmaceuticals Inc's ROA (Return on Assets)
Over recent years, Luckwel Pharmaceuticals Inc's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2021-03-31 | -934.04% |
| 2020-03-31 | -3116.97% |
| 2019-03-31 | -2282.84% |
| 2018-03-31 | -2903.19% |
| 2017-03-31 | -974.82% |
This slight downward trend highlights how Luckwel Pharmaceuticals Inc manages its efficiency in using assets to generate earnings over time.
Comparing Luckwel Pharmaceuticals Inc's ROA (Return on Assets) to Peers
To better understand Luckwel Pharmaceuticals Inc's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Luckwel Pharmaceuticals Inc (LWEL) | -934.04% |
| Jialijia Group Corporation Ltd (RZZN) | -8.12% |
| Vert Infrastructure Ltd (VVV.CN) | -62.53% |
| Preferred Dental Technologies Inc (PDTI.CN) | -67.28% |
| Eviana Health Corp (EHC.CN) | -70.15% |
| Liberty Defense Holdings Ltd (SCAN.V) | -121.39% |
Compared to its competitors, Luckwel Pharmaceuticals Inc's ROA (Return on Assets) is about average compared to peers, indicating typical asset efficiency for the industry.